These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28600627)

  • 1. Ascorbic Acid to Manage Psychiatric Disorders.
    Moretti M; Fraga DB; Rodrigues ALS
    CNS Drugs; 2017 Jul; 31(7):571-583. PubMed ID: 28600627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive and Therapeutic Potential of Vitamin C in Mental Disorders.
    Han QQ; Shen TT; Wang F; Wu PF; Chen JG
    Curr Med Sci; 2018 Feb; 38(1):1-10. PubMed ID: 30074145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of ascorbic acid in the central nervous system: a focus on neurogenic and synaptogenic processes.
    Moretti M; Rodrigues ALS
    Nutr Neurosci; 2022 Nov; 25(11):2431-2441. PubMed ID: 34493165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive and therapeutic potential of ascorbic acid in neurodegenerative diseases.
    Moretti M; Fraga DB; Rodrigues ALS
    CNS Neurosci Ther; 2017 Dec; 23(12):921-929. PubMed ID: 28980404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics of psychoactive drugs.
    Boyadjieva N; Varadinova M
    J Pharm Pharmacol; 2012 Oct; 64(10):1349-58. PubMed ID: 22943166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.
    Millan MJ; Goodwin GM; Meyer-Lindenberg A; Ove Ögren S
    Eur Neuropsychopharmacol; 2015 May; 25(5):599-656. PubMed ID: 25836356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1983 May; 25(635):45-52. PubMed ID: 6843486
    [No Abstract]   [Full Text] [Related]  

  • 8. Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?
    Kocot J; Luchowska-Kocot D; Kiełczykowska M; Musik I; Kurzepa J
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28654017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbic acid in the brain.
    Grünewald RA
    Brain Res Brain Res Rev; 1993; 18(1):123-33. PubMed ID: 8467348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acupuncture, "vital" drugs and psychotropic agents in psychiatric patients. 50 cases].
    Cocchi R; Fusari A; Favuto F; Lorini G
    Minerva Med; 1978 Sep; 69(44):3003-9. PubMed ID: 362243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polyamines and mental diseases].
    Siatkin SP; Svinarev VI; Zaletok SP; Fedoronchuk TV; Berezov TT
    Vestn Ross Akad Med Nauk; 2006; (2):45-51. PubMed ID: 16544905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary studies on CSF gamma-aminobutyric acid levels in psychiatric patients before and during treatment with different psychotropic drugs.
    Zimmer R; Teelken AW; Meier KD; Ackenheil M; Zander KJ
    Prog Neuropsychopharmacol; 1980; 4(6):613-20. PubMed ID: 7220676
    [No Abstract]   [Full Text] [Related]  

  • 13. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1986 Oct; 28(725):99-106. PubMed ID: 3762490
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of valpromide in psychiatric therapeutics].
    Lambert PA; Venaud G
    Encephale; 1987; 13(6):367-73. PubMed ID: 3131112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):32-66. PubMed ID: 19523495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons.
    Ballaz S; Morales I; Rodríguez M; Obeso JA
    J Neurosci Res; 2013 Dec; 91(12):1609-17. PubMed ID: 23996657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
    [No Abstract]   [Full Text] [Related]  

  • 19. [Perspectives of psychiatric pharmacotherapy].
    Hippius H
    Wien Klin Wochenschr Suppl; 1986; 170():7-10. PubMed ID: 3468686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New directions in clinical psychopharmacology.
    Cardoni AA
    Conn Med; 1997 Sep; 61(9):587-95. PubMed ID: 9334514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.